San Diego-based Viking Therapeutics marked itself as a serious competitor while in the weight loss drug marketplace in February immediately after revealing promising info from a mid-phase trial of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when given as a weekly injection As well as in March the c